Featured Events
XSelect from the featured events lightboxes below to access curated content for the given topic.
-
- Search
KYODOWC354136
kyodowc354136
X
![](https://www.newscom.com/zh/editorial-images?p_p_id=listenersearchresults_WAR_searchportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_cacheability=cacheLevelPage&p_p_col_id=column-2&p_p_col_count=1&_listenersearchresults_WAR_searchportlet_struts.portlet.action=%2Fview%2Fwmark&_listenersearchresults_WAR_searchportlet_inputPath=/db/KYO/kyodowc/docs/354/136.thm&tagId=kyodowc354136&size=512" alt="kyodowc354136)
Kobayashi Pharmaceutical Co. President Akihiro Kobayashi speaks at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths. (Kyodo) ==Kyodo
Location:
OSAKA, Japan
Post Date:
Mar 29, 2024 2:00 AM
TAG ID:
kyodowc354136 (RM)
Credit:
Kyodo/Newscom
Format:
1265 x 1549 Color JPEG
Keywords:
Kobayashi Pharmaceutical Co., Akihiro Kobayashi, Osaka, March 29, 2024, fifth death
Release Status:
No Model Release, No Property Release
Please submit a licensing request for pricing on this usage.
